Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma (Liver) - part II

Accession: ST001641
Source / host: Metabolomics Workbench — NIH Metabolomics Workbench
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform:
Organism: unspec
Size (indexed): 22.2 KB (22699 bytes)
Downloaded bytes: 22.2 KB (22699 bytes)
Access / raw: public / OPEN-processed

Download

Files

FileSizeSHA256
ST001641_mwtab.txt12.8 KBcb0d3c837a90af72…
ST001641_factors.json8.8 KBc197a13d668a8306…
ST001641_summary.json590 Bc221c6d3bf6ac735…

Index note: processed mwTab+data+factors; 3 files 22.2 KB

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T04:28:23Z.

About this dataset

This 10x Genomics dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.